In the RA joint, IL-18 activates RA synovial fibroblasts to produce RANKL, M-CSF, GM-CSF, and osteoprotegerin (OPG), which are known osteoclast differentiation factors, resulting in increased bone destruction by osteoclasts [12]. Here, IL18 is linked to rheumatoid arthritis.